This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menendez, D.
Right arrow Articles by Resnick, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Menendez, D.
Right arrow Articles by Resnick, M. A.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, March 2006, p. 2297-2308, Vol. 26, No. 6
0270-7306/06/$08.00+0     doi:10.1128/MCB.26.6.2297-2308.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

The Biological Impact of the Human Master Regulator p53 Can Be Altered by Mutations That Change the Spectrum and Expression of Its Target Genes{dagger}

Daniel Menendez, Alberto Inga,{ddagger} and Michael A. Resnick*

Chromosome Stability Section, Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina 27709

Received 18 August 2005/ Returned for modification 18 September 2005/ Accepted 30 December 2005

Human tumor suppressor p53 is a sequence-specific master regulatory transcription factor that targets response elements (REs) in many genes. p53 missense mutations in the DNA-binding domain are often cancer associated. As shown with systems based on the yeast Saccharomyces cerevisiae, p53 mutants can alter the spectra and intensities of transactivation from individual REs. We address directly in human cells the relationship between changes in the p53 master regulatory network and biological outcomes. Expression of integrated, tightly regulated DNA-binding domain p53 mutants resulted in many patterns of apoptosis and survival following UV or ionizing radiation, or spontaneously. These patterns reflected changes in the spectra and activities of target genes, as demonstrated for P21, MDM2, BAX, and MSH2. Thus, as originally proposed for "master genes of diversity," p53 mutations in human cells can differentially influence target gene transactivation, resulting in a variety of biological consequences which, in turn, might be expected to influence tumor development and therapeutic efficacy.

* Corresponding author. Mailing address: Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, 111 Alexander Drive, Room D342, P.O. Box 12233, Maildrop D3-01, Research Triangle Park, NC 27709. Phone: (919) 541-4480. Fax: (919) 541-7593. E-mail: resnick{at}niehs.nih.gov.

{dagger} Supplemental material for this article may be found at http://mcb.asm.org/.

{ddagger} Present address: Laboratory of Experimental Oncology B, National Cancer Research Institute, IST, Genoa, Italy.

Molecular and Cellular Biology, March 2006, p. 2297-2308, Vol. 26, No. 6
0022-538X/06/$08.00+0     doi:10.1128/MCB.26.6.2297-2308.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Khoo, K. H., Mayer, S., Fersht, A. R. (2009). Effects of Stability on the Biological Function of p53. J. Biol. Chem. 284: 30974-30980 [Abstract] [Full Text]  
  • Yan, J., Menendez, D., Yang, X.-P., Resnick, M. A., Jetten, A. M. (2009). A Regulatory Loop Composed of RAP80-HDM2-p53 Provides RAP80-enhanced p53 Degradation by HDM2 in Response to DNA Damage. J. Biol. Chem. 284: 19280-19289 [Abstract] [Full Text]  
  • Brazdova, M., Quante, T., Togel, L., Walter, K., Loscher, C., Tichy, V., Cincarova, L., Deppert, W., Tolstonog, G. V. (2009). Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences. Nucleic Acids Res 37: 1486-1500 [Abstract] [Full Text]  
  • Singaravelu, K., Devalaraja-Narashimha, K., Lastovica, B., Padanilam, B. J. (2009). PERP, a p53 proapoptotic target, mediates apoptotic cell death in renal ischemia. Am. J. Physiol. Renal Physiol. 296: F847-F858 [Abstract] [Full Text]  
  • Jegga, A. G., Inga, A., Menendez, D., Aronow, B. J., Resnick, M. A. (2008). Functional evolution of the p53 regulatory network through its target response elements. Proc. Natl. Acad. Sci. USA 105: 944-949 [Abstract] [Full Text]  
  • Ma, B., Levine, A. J. (2007). Probing potential binding modes of the p53 tetramer to DNA based on the symmetries encoded in p53 response elements. Nucleic Acids Res 35: 7733-7747 [Abstract] [Full Text]  
  • Vousden, K. H. (2006). Outcomes of p53 activation - spoilt for choice. J. Cell Sci. 119: 5015-5020 [Abstract] [Full Text]  
  • Joerger, A. C., Ang, H. C., Fersht, A. R. (2006). From the Cover: Structural basis for understanding oncogenic p53 mutations and designing rescue drugs. Proc. Natl. Acad. Sci. USA 103: 15056-15061 [Abstract] [Full Text]  
  • Ang, H. C., Joerger, A. C., Mayer, S., Fersht, A. R. (2006). Effects of Common Cancer Mutations on Stability and DNA Binding of Full-length p53 Compared with Isolated Core Domains. J. Biol. Chem. 281: 21934-21941 [Abstract] [Full Text]  
  • Zupnick, A., Prives, C. (2006). Mutational Analysis of the p53 Core Domain L1 Loop. J. Biol. Chem. 281: 20464-20473 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»